International Conference On Malignancies In AIDS And Other Acquired Immunodeficiencies Research Articles

Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa

Oral presentation presented at the 13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011

Cervical cancer epidemiology among HIV-infected women in North America

Cervical cancer epidemiology among HIV-infected women in North America Gypsyamber D’Souza, Yuezhou Jing, Howard Strickler, Michael Silverberg, Eric Engels, Ronald Bosch, John T Brooks, Robert Dubrow, Joseph Eron, Kelly Gebo, M J Gill, Bob Hogg, Mari Kitahata, Marina Klein, Richard Moore, Sean Rourke, Alison G Abraham From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease

KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman’s disease Mark N Polizzotto, Thomas S Uldrick, Victoria Wang, Karen Aleman, Kathleen M Wyvill, Vickie Marshall, Stefania Pittaluga, Dierdre O’Mahony, Denise Whitby, Giovanna Tosato, Seth M Steinberg, Richard F Little, Robert Yarchoan From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naive patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa A Mosam, F Shaik, TS Uldrick, GH Friedland, DT Scadden, J Aboobaker, HM Coovadia From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Phase IIA trial of 1% topical cidofovir for treatment of high-grade perianal squamous intraepithelial neoplasia in HIV-infected men and women (AMC046)

Phase IIA trial of 1% topical cidofovir for treatment of high-grade perianal squamous intraepithelial neoplasia in HIV-infected men and women (AMC046) Elizabeth A Stier, Stephen E Goldstone, Mark H Einstein, Naomi Jay, J Michael Berry, Timothy Wilkin, Jeannette Lee, Lori Panther, David Aboulafia, Joel Palefsky From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Côte d’Ivoire

Challenges in integrating cervical cancer screening in HIV care clinics in West Africa: a pilot study in Abidjan, Cote d’Ivoire Apollinaire Horo, Antoine Jaquet, Badian Toure, Didier K Ekouevi, Severin Lenaud, Benjamin Effi, Annie J Sasco, Eugene Messou, Emmanuel Bissagniene, Mamourou Kone, Francois Dabis From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Elevated serum levels of heat shock protein 70 precede the development of AIDS-non-Hodgkin lymphoma in carriers of the common and highly conserved HLA-B8-DR3 haplotype

Elevated serum levels of heat shock protein 70 precede the development of AIDS-non-Hodgkin lymphoma in carriers of the common and highly conserved HLA-B8-DR3 haplotype Brahim Aissani, Otoniel Martinez-Maza, Sadeep Shrestha, Elizabeth Breen, Lisa Jacobson, Richard Kaslow From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana

Type distribution of human papillomavirus in HIVinfected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana Doreen Ramogola-Masire, Nicola M Zetola, Veronica de Klerk, Barati Monare, Bakgaki Ratshaa, Gracious Ditlhabang, Elisabeth Chibaya, Metlha Nchunga, Mukendi K Kayembe, Kurt T Barnhart, Cindy M McGrath, Harvey M Friedman From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Integrative proteomics and genomics supports a role for interferon gamma in the pathogenesis of Kaposi sarcoma and finds multiple candidate diagnostic proteins for early detection or prevention

Integrative proteomics and genomics supports a role for interferon gamma in the pathogenesis of Kaposi sarcoma and finds multiple candidate diagnostic proteins for early detection or prevention Lynn Amon, Jennifer Gross, Jackson Orem, Innocent Mutyaba, Warren Phipps, Kurt Diem, Meei-Li Huang, Lawrence Corey, Martin McIntosh, Corey Casper From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates

Characterization of lytic human herpesvirus-8 gene expression in Kaposi sarcoma tumor tissue and its clinical correlates Warren Phipps, Jackson Orem, Innocent Mutyaba, James Ferrenberg, Misty Saracino, Meei-Li Huang, Jeff Vieira, Anna Wald, Larry Corey, Corey Casper From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD) Thomas Uldrick, Mark Polizzotto, Deirdre O’Mahony, Karen Aleman, Kathy Wyvill, Seth M Steinberg, Stefania Pittaluga, Vickie Marshall, Denise Whitby, Giovanna Tosato, Richard F Little, Robert Yarchoan From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas

The use of high-dose azidothymidine in combination with chemotherapy upfront is an effective treatment approach for gamma-herpes virus-related non-Hodgkin’s lymphomas Ulas Darda Bayraktar, Eileen Bernal, Lisa Cabral, William J Harrington Jr., Dirk P Dittmer, Juan Carlos Ramos From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Kaposi sarcoma in South African children

This article has been published as part of Infectious Agents and Cancer Volume 5 Supplement 1, 2010: Proceedings of the 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI).

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration Gabriela D’Jaen, Liron Pantanowitz, Mark Bower, Susan Buskin, Nancy Neil, Erin Greco, Timothy Cooley, David Henry, Jonathan Stem, Bruce Dezube, Justin Stebbing, David Aboulafia From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

Reasons for not adhering to cervical cancer screening guidelines and HPV knowledge among HIV indeterminate midlife women (50-64 years old) whose last Pap test was >6 years ago

Reasons for not adhering to cervical cancer screening guidelines and HPV knowledge among HIV indeterminate midlife women (50-64 years old) whose last Pap test was >6 years ago Lisa T Wigfall, Heather M Brandt, Donna L Richter, Wayne A Duffus, Saundra H Glover From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010

The approach to individualized prediction of human papillomavirus (HPV) infection persistence/clearance in HIV-1-positive adolescent girls based on dynamics of CD4+ counts, viral load, and HAART

The approach to individualized prediction of human papillomavirus (HPV) infection persistence/clearance in HIV-1-positive adolescent girls based on dynamics of CD4+ counts, viral load, and HAART Julia Kravchenko, Staci Sudenga, Igor Akushevich, Craig M Wilson, Sadeep Shrestha From 12 International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 26-27 April, 2010